EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.216
March 31, 2026 -1.244
December 31, 2025 -1.280
September 30, 2025 -1.362
June 30, 2025 -1.387
March 31, 2025 -1.406
December 31, 2024 -1.390
September 30, 2024 -1.30
June 30, 2024 -1.281
March 31, 2024 -1.295
December 31, 2023 -1.352
September 30, 2023 -1.433
June 30, 2023 -1.487
March 31, 2023 -1.485
Date Value
December 31, 2022 -1.489
September 30, 2022 -1.451
June 30, 2022 -1.368
March 31, 2022 -1.276
December 31, 2021 -1.169
September 30, 2021 -1.060
June 30, 2021 -0.8949
March 31, 2021 -0.7222
December 31, 2020 -0.5381
September 30, 2020 -0.4102
June 30, 2020 -0.2751
March 31, 2020 -0.1747
December 31, 2019 -0.0845

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Champions Oncology, Inc. -0.0802
Medpace Holdings, Inc. 17.05
Avantor, Inc. -0.8468
Personalis, Inc. -1.091
Adaptive Biotechnologies Corp. -0.4079